首页> 外文期刊>Southern Med Review >Public procurement of medicines: scoping review of the scientific literature in South America
【24h】

Public procurement of medicines: scoping review of the scientific literature in South America

机译:药物的公共采购:南美科学文学的研究综述

获取原文
           

摘要

Background Access to medicines is essential for materializing access to health as a fundamental human right. As such, it is included in the United Nations Sustainable Development Goals [ 1 ], and is recognized as key-element for scaling-up access to health services towards universal health coverage [ 2 ]. Pharmaceutical services are not restricted to the logistical component of medicines availability. They also include management and quality of services, and promotion of adequate use of medicines. Even though, the availability of medicines is an extremely important dimension for the assurance of access to these products [ 3 ]. The scenario of intensification of technological innovations, the price of medicines has been a barrier to access, especially in low- and middle-income countries. In a context of expanding social policies in South America in the first decade of the twenty-first century, public procurement imposed negotiation processes and strategies to reduce the price of medicines. Medicines have a major impact on governments, health care providers and household spending. Data from the Brazilian Health Satellite Account show that total government expenditures with medicines reached US$ 3,268,468 in 2015, representing a 54% increase over 2010 expenditures. Nevertheless, this represent around half of the household health expenditure, with a greater impact on the poorest families [ 4 ]. Barcelo et al. [ 5 ] estimated the per capita cost to treat diabetes mellitus in Latin America and the Caribbean (LAC) between US$ 1088 and US$ 1818 annually. In the same period, the average per capita of health care expenditure was US$ 1061 in LAC and medicines as a single item were responsible for a total of US$ 11–18 billion. Availability is directly related to the procurement of medicines. Although there are different models and configurations of health systems, government procurement is an activity performed by all of them. It is as a tool for the fulfillment of public assignments, such as providing services to society, and its attainment is fundamental to the managerial and financial rationality of public administration. Government procurement is a type of public purchase carried out by entities linked to the State such as public companies and mixed-capital companies, and is governed by specific regulations of each country or region [ 6 ]. The difficult balance between best quality and low price has been a challenge in most countries. One reason for that is the lack of a standardized set of key-quality criteria for procurement monitoring and evaluation that promote transparency and improve governance. In order to contribute to reduce this gap, it is worth analyzing how the scientific community has focused on this theme. The present work aims to map the scientific production regarding processes of medicines public procurement in South American countries, with the objective of identifying main aspects discussed in peer-reviewed articles. Main text Methods The method of scoping review systematized by Arksey and O’Malley [ 7 ] was used as tool for mapping scientific production, by including territorial and time variables. The present study covered 12?years, from 2005 - when it was held the second round of sub-regional antiretroviral (ARV) price negotiations in South America [ 8 ] - to 2017, of scientific production in articles published in English, Portuguese and Spanish in peer-reviewed journals. Given the importance of the above-mentioned price negotiation initiative, it is reasonable to expect that the event led to publication of studies in scientific journals. Research question What is the scope and aspects discussed in the peer-reviewed articles on processes of medicines public procurement in South American countries? Data sources and search strategies The search was carried out in the bibliographic databases SCOPUS, WEB OF SCIENCE (ISI), SCIELO, MEDLINE via PUBMED, EMBASE and Virtual Health Library (VHL), covering the fields of knowledge of health, social and human sciences. The Health Sciences Descriptors and keywords used in the study are listed in Table? 1 , with application of filtering per year of publication from 2005 to 2017. Table 1 Search strategy for scientific publications on procurement of medicines in South America, syntax by database, from 2005 to 2017 Full size table The selection of articles and extraction of data were performed independently by two of the authors; a third author resolved disagreements. Eligibility criteria The publications were selected when they focused on the procurement of medicines for public purposes and included at least one South American country at the regional, national and subnational levels. Consortium purchase cases were included regardless of population size, as well as studies of government expenditures and international price comparisons, as long as they included the public sector. It was decided to use the term “public purchase” to cover also the purchases made b
机译:背景技术对药品的访问对于实现对健康的获得作为基本人权至关重要。因此,它被列入联合国可持续发展目标[1],被认为是扩大对普遍健康覆盖率的卫生服务获得的关键因素[2]。制药服务不限于药品可用性的后勤组成部分。他们还包括服务的管理和质量,促进充分使用药物。尽管如此,药物的可用性是一种极其重要的维度,用于保证对这些产品的访问[3]。技术创新的强化方案,药物价格是访问的障碍,特别是在低收入和中等收入国家。在二十一世纪的第一个十年扩大南美洲的社会政策的背景下,公共采购施加了谈判进程和战略,以降低药物价格。药物对各国政府,医疗保健提供者和家庭支出产生了重大影响。巴西卫生卫星账户的数据显示,2015年医药的政府总支出达到3,268,468美元,而2010年的支出增加54%。尽管如此,这大约有一半的家庭健康支出,对最贫穷的家庭产生了更大的影响[4]。巴塞罗等人。 [5]估计人均成本在拉丁美洲和加勒比地区(LAC)每年在1088美元至1818美元之间治疗糖尿病患者。在同一时期,卫生保健支出的平均人民币为1061美元,加仑和药品,作为单一项目负责11-180亿美元。可用性与药物采购直接相关。虽然有不同的型号和卫生系统配置,但政府采购是所有的活动。它是履行公共作用的工具,例如为社会提供服务,其成就是公共行政管理和财务合理性的基础。政府采购是由与公共公司和混合资本公司等国家相关的实体进行的一系列公开购买,并受到每个国家或地区的具体规定的管辖[6]。最优质和低价格之间的艰难平衡在大多数国家都是一个挑战。其中一个原因是缺乏用于采购监测和评估的标准化的关键质量标准,促进透明度和改善治理。为了有助于减少这种差距,值得分析科学界如何专注于此主题。目前的工作旨在映射南美国家的药物公共采购过程的科学生产,目的是确定同行评审条款中讨论的主要方面。主要文本方法Arksey和O'Malley系统化的范围审查方法[7]被用作映射科学生产的工具,包括领土和时间变量。目前的研究涉及12年,从2005年举行 - 当它在南美洲的第二轮次区域抗逆转录病毒(ARV)价格谈判中[8] - 2017年,在英语,葡萄牙语和西班牙语发表的文章中的科学生产在同行评审期刊中。鉴于上述价格谈判倡议的重要性,预计该活动导致在科学期刊上发表研究是合理的。研究问题是对南美国家的药物公共采购进程的同行评审条款中讨论的范围和方面是什么?数据来源和搜索策略搜索是在书目数据库SCopus,科学网站(ISI),SCIELO,MEDLINE通过PUBMED,EMBASE和虚拟健康库(VHL)中进行的,涵盖了健康,社会和人类科学的知识领域。表中列出了研究中使用的健康科学描述符和关键字? 1,每年从2005年到2017年的出版物过滤。表1表1在南美洲药物采购的科学出版物的搜索策略,数据库的语法,2005年到2017年全尺寸表的选择和提取数据的选择和提取数据由两个作者独立执行;第三作者解决了分歧。资格标准当他们专注于用于公开目的的药物并包括在区域,国家和地合层面的至少一个南美国家的采购时,选择了出版物。无论人口规模,以及政府支出和国际价格比较的研究,包括联盟购买案例,只要他们包括公共部门,就包括对政府支出和国际价格比较。它决定使用“公共购买”一词来覆盖购买B制作B.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号